Literature DB >> 7981389

Parametric approaches to quality-adjusted survival analysis. International Breast Cancer Study Group.

B F Cole1, R D Gelber, K M Anderson.   

Abstract

We present a parametric methodology for performing quality-of-life-adjusted survival analysis using multivariate censored survival data. It represents a generalization of the nonparametric Q-TWiST method (Quality-adjusted Time without Symptoms and Toxicity). The event times correspond to transitions between states of health that differ in terms of quality of life. Each transition is governed by a competing risks model where the health states are the competing risks. Overall survival is the sum of the amount of time spent in each health state. The first step of the proposed methodology consists of defining a quality function that assigns a "score" to a life having given health state transitions. It is a composite measure of both quantity and quality of life. In general, the quality function assigns a small value to a short life with poor quality and a high value to a long life with good quality. In the second step, parametric survival models are fit to the data. This is done by repeatedly modeling the conditional cause-specific hazard functions given the previous transitions. Covariates are incorporated by accelerated failure time regression, and the model parameters are estimated by maximum likelihood. Lastly, the modeling results are used to estimate the expectation of quality functions. Standard errors and confidence intervals are computed using the bootstrap and delta methods. The results are useful for simultaneously evaluating treatments in terms of quantity and quality of life. To demonstrate the proposed methods, we perform an analysis of data from the International Breast Cancer Study Group Trial V, which compared short-duration chemotherapy versus long-duration chemotherapy in the treatment of node-positive breast cancer. The events studied are: (1) the end of treatment toxicity, (2) disease recurrence, and (3) overall survival.

Entities:  

Mesh:

Year:  1994        PMID: 7981389

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  7 in total

1.  Some Geometric Methods for Constructing Decision Criteria Based On Two-Dimensional Parameters.

Authors:  Peter F Thall
Journal:  J Stat Plan Inference       Date:  2008       Impact factor: 1.111

2.  The Q-TWiST approach to assessing health-related quality of life in epilepsy.

Authors:  C E Schwartz; B F Cole; B G Vickrey; R D Gelber
Journal:  Qual Life Res       Date:  1995-04       Impact factor: 4.147

3.  A Q-TWiST analysis comparing panitumumab plus best supportive care (BSC) with BSC alone in patients with wild-type KRAS metastatic colorectal cancer.

Authors:  J Wang; Z Zhao; B Barber; B Sherrill; M Peeters; J Wiezorek
Journal:  Br J Cancer       Date:  2011-05-24       Impact factor: 7.640

4.  Analyzing composite outcomes in cardiovascular studies: traditional Cox proportional hazards versus quality-of-life-adjusted survival approaches.

Authors:  Dean T Eurich; Sumit R Majumdar; Finlay A McAlister; Ross T Tsuyuki; Yutaka Yasui; Jeffrey A Johnson
Journal:  Open Med       Date:  2010-02-23

5.  Modelled Economic Analysis for Dacomitinib-A Cost Effectiveness Analysis in Treating Patients With EGFR-Mutation-Positive Non-Small Cell Lung Cancer in China.

Authors:  Yong-Feng Yu; Luan Luan; Fan-Fan Zhu; Peng Dong; Li-Heng Ma; Lan-Ting Li; Lan Gao; Shun Lu
Journal:  Front Oncol       Date:  2021-12-14       Impact factor: 6.244

6.  Q-TWiST analysis comparing ipilimumab/dacarbazine vs placebo/dacarbazine for patients with stage III/IV melanoma.

Authors:  B Sherrill; J Wang; S Kotapati; K Chin
Journal:  Br J Cancer       Date:  2013-06-20       Impact factor: 7.640

7.  Comparative quality-adjusted survival analysis between radiation therapy alone and radiation with androgen deprivation therapy in patients with locally advanced prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 85-31 with novel decision analysis methods.

Authors:  Soyeon Ahn; Minjung Lee; Chang Wook Jeong
Journal:  Prostate Int       Date:  2018-02-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.